PD38: Prostate Cancer: Detection & Screening IV

Podium Session Moderator(s)

• AA

  Andre Luis Abreu, MD (he/him/his)

  Associate Professor of Clinical Urology and Radiology
  University Of Southern California
• 

  Giuseppe Carrieri, MD

  University of Foggia, Italy
• 

  J. Stephen Jones, MD

  President & CEO, Inova Health System
  University of Virginia

Presentations:

• 3:30 PM – 3:40 PM CST

  PD38-01: Negative Predictive Value of Prostate MRI in Real World Practice: Results from a Statewide Surgical Collaborative
  

  Podium Presenter: Alex Zhu, DO – University of Washington
• 3:40 PM – 3:50 PM CST

  PD38-02: BPH-related False Positive of ⁶⁸Ga-PSMA PET/CT in the Diagnosis of Prostate Cancer: the Achilles' Heel of Biopsy-free Radical Prostatectomy?
  

  Podium Presenter: Wei Tang, MD – Xiangya Hospital of Central South University
• 3:50 PM – 4:00 PM CST

  PD38-03: How many transrectal fusion prostate biopsies needed from a lesion on MRI for accurate diagnosis of significant prostate cancer?
  

  Podium Presenter: David Dothan, MD – Roswell Park Cancer Institute
• 4:00 PM – 4:10 PM CST

  PD38-04: Metabolic heterogeneity of human prostate cancer based on ¹⁸F-PSMA-1007 and ¹⁸F-FDG PET/CT and its clinicopathologic characteristics
  

  Podium Presenter: Sungun Bang, MD – Severance Hospital of Yonsei University College of
• 4:10 PM – 4:20 PM CST

  PD38-05: Is Routine Antibiotic Prophylaxis Required for Transperineal Prostate Biopsy?
  

  Podium Presenter: Apoorv Dhir, MD (he/him/his)
• 4:20 PM – 4:30 PM CST

  PD38-06: What is the ideal number of cores to collect per region of interest during targeted prostate biopsy?
  

  Podium Presenter: Casey Brodsky, PhD (she/her/hers) – University of Michigan
• 4:30 PM – 4:40 PM CST

  PD38-07: Stimulated Raman Histology Interpretation By Artificial Intelligence Can Provide Real-Time Pathologic Feedback of Prostate Biopsies
  

  Podium Presenter: Miles Mannas, MD – University of British Columbia
• 4:40 PM – 4:50 PM CST

  PD38-08: Avoiding unnecessary targeted prostate biopsies using machine learning
  

  Podium Presenter: Roxana Esmaili – Yale University
• 4:50 PM – 5:00 PM CST

  PD38-09: Free PSA and clinically significant and fatal prostate cancer in the PLCO Screening Trial
  

  Podium Presenter: Kendrick Yim, MD – Brigham and Women's Hospital
• 5:00 PM – 5:10 PM CST

  PD38-10: Disparities in PSA Testing Rates for Veterans with Spinal Cord Injury
  

  Podium Presenter: Sarah Kodama, BS – Virginia Commonwealth University
• 5:10 PM – 5:20 PM CST

  PD38-12: Natural History of Small Index Lesions on Multiparametric MRI: Implications for Active Surveillance
  

  Podium Presenter: Neil Mendhiratta, MD – National Cancer Institute